S-1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas-Reference-Cited by-同舟云学术

S-1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas

Published:2014-08-08 Issue:11 Volume:38 Page:2986-2993
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Okabayashi Takehiro,Shima Yasuo,Iwata Jun,Morita Sojiro,Sumiyoshi Tatsuaki,Kozuki Akihito,Tokumaru Teppei,Iiyama Tatsuo,Kosaki Takuhiro,Kobayashi Michiya,Hanazaki Kazuhiro

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-014-2703-z.pdf

Reference26 articles.

1. Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277

2. Neoptolemos JP, Stocken DD, Friess H et al (2004) European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

3. Choti MA (2004) Adjuvant therapy for pancreatic cancer–the debate continues. N Engl J Med 350:1249–1251

4. Michalski CW, Kleeff J, Wente MN et al (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273

5. Konstantinidis IT, Warshaw AL, Allen JN et al (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for r1 resections versus locally advanced unresectable tumors? what is a “true” r0 resection? Ann Surg 257:731–736

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can preoperative Carbohydrate Antigen 19-9 predict metastatic pancreatic cancer? Results of a systematic review and meta-analysis;HPB;2024-05

2. Preoperative C-Reactive Protein-to-Albumin Ratio and Its Ability to Predict Outcomes of Pancreatic Cancer Resection: A Systematic Review;Biomedicines;2023-07-13

3. Multidisciplinary team diagnosis and treatment of pancreatic cancer: Current landscape and future prospects;Frontiers in Oncology;2023-03-15

4. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer;International Journal of Clinical Oncology;2021-06-10

5. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers;Medicine;2019-11